Personal stories

Treating patients day and night is just one part of the job description for this enterprising nurse, who has made it her mission to help fellow nurses persevere during the pandemic and beyond. And it’s not her first great healthcare innovation.

Imagine getting so sick from a preventable disease that you can’t play or attend school—multiple times a year. For World Children’s Day, we’re sharing the story of Sheti and others just like her who now have a chance to take back their childhoods, thanks to a new formulation of a medication to treat intestinal worms.

Johnson & Johnson and the National Academy of Medicine have collaborated on a competition to kick-start research that’s poised to revolutionize the field of healthy longevity. Meet some of the researchers who have big ideas in the pursuit of “immorbidity.”

A foldable, 3-D printed robot that can serve as a heart stent. Using artificial intelligence to help detect cancer. Seeking out life on other planets. These are just some of the areas of fascinating research that this year’s winners of the Johnson & Johnson WiSTEM²D Scholars Award are focused on in their labs across the country.

Taubert, who has helped guide the Janssen Pharmaceutical Companies of Johnson & Johnson during the COVID-19 pandemic, has been honored on the annual list for the fifth year in a row.

In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.

Check out this infographic breakdown of the company’s third-quarter 2020 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

For the 35th year in a row, Johnson & Johnson has been named to Working Mother’s 100 Best Companies list—and these two employees were named Working Mother and Working Dad of the Year for their incredible strength in the face of adversity.

Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., were just honored with the prestigious award for their work with gene-editing technology CRISPR. But they also have a connection to Johnson & Johnson—they were awarded the Dr. Paul Janssen Award in 2014. Learn more about what makes them so impressive.